comparemela.com

Latest Breaking News On - Pharmaceuticals trading down - Page 33 : comparemela.com

Titan Pharmaceuticals (NASDAQ:TTNP) Now Covered by StockNews.com

Investment analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Trading Down 8.7 % TTNP stock opened at $6.29 on Friday. The business’s 50-day moving average is $6.93 and […]

Canada
United-states
News-ratings-for-titan-pharmaceuticals-daily
Institutional-investors-weigh-in-on-titan-pharmaceuticals
European-union
Renaissance-technologies
Titan-pharmaceuticals-inc
Virtu-financial
Titan-pharmaceuticals-trading-down
Titan-pharmaceuticals
Millennium-management

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $51.25 Consensus Price Target from Analysts

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $51.25 Consensus Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
Canada
America
Arrowhead-pharmaceuticals
Hedge-funds-weigh-in-on-arrowhead-pharmaceuticals
Securities-exchange-commission
Citigroup
Morgan-stanley
Nasdaq
Arrowhead-pharmaceuticals-trading-down

Legato Capital Management LLC Buys 7,431 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Legato Capital Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 95.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,217 shares of the company’s stock after purchasing an additional 7,431 shares during the period. Legato […]

United-states
France
China
Michaela-zasloff
Maryz-luo
Covestor-ltd
Tower-group
Legato-capital-management
Jpmorgan-chase-co
Quarter-for-amphastar-pharmaceuticals
Nasdaq

Needham & Company LLC Reiterates Buy Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)

Needham & Company LLC restated their buy rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $220.00 target price on the specialty pharmaceutical company’s stock. JAZZ has been the subject of several other reports. Barclays reduced their price […]

Canada
Los-angeles
California
United-states
Blackrock
Philipl-johnson
Patricia-carr
Insider-transactions-at-jazz-pharmaceuticals
Barclays
News-ratings-for-jazz-pharmaceuticals-daily
Thompson-siegel-walmsley
Analyst-recommendations-for-jazz-pharmaceuticals

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells $664,821.34 in Stock

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) insider Dana Pizzuti sold 15,089 shares of the company’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $44.06, for a total value of $664,821.34. Following the completion of the transaction, the insider now owns 27,786 shares […]

China
Dana-pizzuti
Robertw-baird
Crinetics-pharmaceuticals-trading-down
News-ratings-for-crinetics-pharmaceuticals-daily
Osaic-holdings-inc
Quarter-for-crinetics-pharmaceuticals
China-universal-asset-management-co
Nasdaq
Crinetics-pharmaceuticals
Tower-research-capital
Jefferies-financial-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.